4//SEC Filing
GOLDENBERG CYNTHIA L 4
Accession 0001171843-17-005276
CIK 0000722830other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 8:54 PM ET
Size
9.8 KB
Accession
0001171843-17-005276
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
GOLDENBERG CYNTHIA L
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2017-08-24$10.24/sh−25,000$256,105→ 813,219 total - Sale
Common Stock
2017-08-28$11.45/sh−5,000$57,250→ 808,219 total - Sale
Common Stock
2017-08-28$11.56/sh−10,000$115,591→ 798,219 total
Holdings
- 5,128,014(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31.
- [F2]The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- [F3]Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer.
- [F4]The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59.
- [F5]Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
Documents
Issuer
IMMUNOMEDICS INC
CIK 0000722830
Entity typeother
Related Parties
1- filerCIK 0001202016
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 8:54 PM ET
- Size
- 9.8 KB